<p>D&#38;D Pharmatech presented preclinical findings for its obesity treatment candidate DD18 at ObesityWeek 2026 in National Harbor, Maryland, highlighting its potential to reduce body fat while increasing lean body mass. The post D&amp;D Pharmatech advances obesity candidate with muscle-preserving po</p>